Defence Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is July - June.

Millions CAD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2019 - 2020
Period Ending	Oct '25 Oct 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2019 - 2020
Market Capitalization	42	38	34	128	73	245	Upgrade
Market Cap Growth	56.84%	13.68%	-73.58%	74.18%	-70.15%	-	Upgrade
Enterprise Value	42	38	35	126	72	239	Upgrade
Last Close Price	0.77	0.70	0.74	2.92	2.00	7.05	Upgrade
PB Ratio	-33.55	-30.50	-9.40	81.44	-188.95	44.72	Upgrade
P/TBV Ratio	-	-	-	83.51	-	45.09	Upgrade
Debt / Equity Ratio	-1.20	-1.20	-0.49	1.12	-	-	Upgrade
Quick Ratio	0.49	0.49	0.04	13.35	0.48	45.19	Upgrade
Current Ratio	0.50	0.50	0.05	15.58	0.61	45.51	Upgrade
Return on Equity (ROE)	-	-	-	-1147.59%	-288.03%	-77.80%	Upgrade
Return on Assets (ROA)	-187.25%	-187.25%	-397.30%	-190.91%	-143.66%	-46.96%	Upgrade
Return on Capital (ROIC)	-	-	-1080.63%	-277.57%	-178.30%	-48.05%	Upgrade
Earnings Yield	-8.36%	-9.19%	-39.15%	-5.30%	-10.03%	-1.17%	Upgrade
FCF Yield	-8.06%	-8.87%	-13.33%	-6.05%	-8.25%	-0.93%	Upgrade
Buyback Yield / Dilution	-11.64%	-11.64%	-12.54%	-9.93%	-35.65%	-2719.76%	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.